Patents by Inventor Michael Francis Gross

Michael Francis Gross has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6858611
    Abstract: Compounds which are useful as potassium channel inhibitors and which because of their slow off-rates are especially useful for the treatment of cardiac arrhythmias are described.
    Type: Grant
    Filed: March 19, 2003
    Date of Patent: February 22, 2005
    Assignee: Icagen, Inc.
    Inventors: Aimee Dolores Reed, Michael Francis Gross, Serge Beaudoin
  • Publication number: 20030236261
    Abstract: Compounds which are useful as potassium channel inhibitors and which because of their slow off-rates are especially useful for the treatment of cardiac arrhythmias are described.
    Type: Application
    Filed: March 19, 2003
    Publication date: December 25, 2003
    Applicant: Icagen, Inc.
    Inventors: Aimee Dolores Reed, Michael Francis Gross, Serge Beaudoin
  • Patent number: 6566380
    Abstract: Compounds which are useful as potassium channel inhibitors and which because of their slow off-rates are especially useful for the treatment of cardiac arrhythmias are described.
    Type: Grant
    Filed: July 24, 2001
    Date of Patent: May 20, 2003
    Assignee: ICAgen, Inc.
    Inventors: Aimee Dolores Reed, Michael Francis Gross, Serge Beaudoin
  • Publication number: 20030027829
    Abstract: Compounds which are useful as potassium channel inhibitors and which because of their slow off-rates are especially useful for the treatment of cardiac arrhythmias are described.
    Type: Application
    Filed: July 24, 2001
    Publication date: February 6, 2003
    Inventors: Aimee Dolores Reed, Michael Francis Gross, Serge Beaudoin
  • Publication number: 20020013349
    Abstract: The present invention relates to a novel method of treating of pain or anxiety, using compounds that modulate KCNQ potassium channels and currents.
    Type: Application
    Filed: August 24, 2001
    Publication date: January 31, 2002
    Inventors: Alan David Wickenden, Gregory Cooksey Rigdon, Grant Andrew McNaughton-Smith, Michael Francis Gross
  • Patent number: 6326385
    Abstract: The present invention relates to a novel method of treating of pain, using compounds that modulate KCNQ potassium channels and currents.
    Type: Grant
    Filed: August 4, 2000
    Date of Patent: December 4, 2001
    Assignee: ICAgen, Inc.
    Inventors: Alan David Wickenden, Gregory Cooksey Rigdon, Grant Andrew McNaughton-Smith, Michael Francis Gross